Edap Tms S.A. (EDAP) 3.13 $EDAP
EDAP's HIFU and Lithotripsy Devices Highlighted at 29th Annual EAU Congress
GlobeNewswire - Thu Apr 10, 7:30AM CDT
EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced its participation at the European Association of Urology (EAU) 2014 Annual Congress that will be held in Stockholm on April 11-15, 2014. EDAP's HIFU and lithotripsy device portfolio will be featured in multiple poster sessions.
EDAP Reports Fourth Quarter 2013 and Full Year Results
GlobeNewswire - Thu Apr 03, 6:30AM CDT
Highlights
EDAP Completes FDA Q&A Session for Its Ablatherm-HIFU Pre-Market Approval Application
GlobeNewswire - Thu Mar 20, 10:01AM CDT
EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that it has completed its response to questions from the FDA regarding the Company's Ablatherm-HIFU Pre-Market Approval ("PMA"
application, closing this step within the U.S. Food and Drug Administration ("FDA" review process.
Global Ablation Technologies Market 2012-2016: Major Cancer Diseases that Use Ablation Technology Devices are Discussed in Detail
M2 - Mon Mar 10, 11:24AM CDT
Research and Markets (http://www.researchandmarkets.com/research/5z78kx/global_ablation) has announced the addition of the "Global Ablation Technologies Market 2012-2016" report to their offering. The analysts forecast the Global Ablation Technologies market to grow at a CAGR of 10.52 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increased demand for minimally invasive surgical procedures. The Global Ablation Technologies market has also been witnessing the trend of miniaturizing medical devices. However, the varying regulations for medical devices could pose a challenge to the growth of this market. Ablation technology devices are used for various clinical applications and Cancer therapy, and accounted for the largest segment of the Global Ablation Technologies market. The key vendors dominating this market space include Boston Scientific Corp., Medtronic Inc., St.Jude Medical Inc., and Varian Medical Systems Inc. The other vendors mentioned in the report are Accuray Inc., Alcon Laboratories Inc., AngioDynamics Inc., Arthrocare Corp., Atricure Inc., ATS Medical Inc., Biosense Webster Inc., BSD Medical Corporation, C.R. Bard Inc., Candela Corp., CardioGenesis Corp., CermaVEIN SAS, ConMed Corporation, Covidien plc, EDAP TMS S.A., Elekta AB, Endo Health Solutions Inc., Galil Medical Ltd., HealthTronics Inc., Hologic Inc., Idoman Ltd., Maquet Holding GmbH and Co. KG (Gentinge AB group), Microsulis Medical Ltd, Misonix Inc., nContact Surgical Inc., Olympus Corp., Relievant Medsystems, Rhythmia Medical Inc., Smith and Nephew plc, Solta Medical Inc., Syneron Medical Ltd., TheraGenics Corp., Urologix Inc., VNUS Medical Technologies Inc., and Zeltiq Aesthetics Inc. Commenting on the report, an analyst from the Healthcare team said: One of the upcoming trends in the Global Ablation Technology market is the rapid advancements in technology using ablation technology devices. Although the market for ablation technology devices is at a mature stage, the level of technology is still at a nascent stage; more devices with cutting-edge technology are expected to be introduced in the near future. Recently, laser ablation devices have been introduced to perform precise ablation of body tissue; these devices run on a laser energy transmission mechanism using fiber optics. This kind of device is used in transmyocardial revascularization and angioplasty. Another major advancement is the usage of catheter ablation for atrial fibrillation, which is commonly used to control tachy-arrhythmia. Thus, the rapid advancement in technology is an emerging trend that has a strong impact on the market. For more information visit http://www.researchandmarkets.com/research/5z...l_ablation About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
PowerShares Canada to adjust NAV on three ETFs
CNW Group - Thu Feb 20, 5:00PM CST
PowerShares Canada announced today that it will adjust the net asset value (NAV) of three TSX-listed PowerShares exchange-traded funds (the "ETFs" effective Friday, February 21, 2014.
EDAP Delivers Focal One(R) Device for Focal Treatment of Prostate Cancer to Hospital in Poland
GlobeNewswire - Tue Feb 11, 7:30AM CST
EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today the installation of its Focal One device at the ESKULAP Private Hospital in Bydgoszcz, Poland. Focal One is the first robotic HIFU device dedicated to the focal approach for prostate cancer therapy. It combines the three essential components to efficiently perform a focal treatment: state-of-the-art imaging to localized tumors with the use of magnetic resonance imaging (MRI) combined with real-time ultrasound, utmost precision of robotic HIFU treatment focused only on identified targeted cancer areas, and immediate feedback on treatment efficacy utilizing Contrast-Enhanced Ultrasound Imaging.
EDAP Schedules Webcast and Conference Call for Fourth Quarter and Full Year 2013 Results
GlobeNewswire - Mon Feb 10, 7:41AM CST
EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today details relating to its fourth quarter and full year 2013 results announcement, which will take place on Thursday, April 3, 2014, before the opening of the market.
EDAP Reports Third Quarter 2013 Results
GlobeNewswire - Thu Nov 21, 6:30AM CST
EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today financial results for the third quarter ended September 30, 2013.
EDAP Schedules Webcast and Conference Call for Third Quarter 2013 Results
GlobeNewswire - Thu Oct 31, 7:30AM CDT
EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today details relating to its third quarter 2013 results announcement, which will take place on Thursday, November 21, 2013, before the opening of the market.
EDAP's Ablatherm-HIFU to be Showcased at 31st World Congress of Endourology
GlobeNewswire - Tue Oct 22, 8:00AM CDT
EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that its high-intensity focused ultrasound (HIFU) for the treatment of localized prostate cancer, Ablatherm-HIFU, will be featured in multiple presentations addressing minimally invasive prostate cancer therapies and the successful evaluation of EDAP's device at the 31 World Congress of Endourology (WCE). Top level technical presentations will be made from key opinion leaders in urology, including Dr. Chaussy Christian, Department of Urology, University of Regensburg, Dr. Thuroff Stefan, Department of Urology, Klinikum Munchen Harlaching, and Dr. Sebastian Crouzet, Urologist at Edouard Herriot Hospital in Lyon, France. The WCE is scheduled to take place from October 22-26, 2013, in New Orleans, LA.
OTC Daily Alert Stock Watch - EDAP TMS S.A (NASDAQ: EDAP)
WorldStockWire - Tue Sep 17, 1:46AM CDT
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com
EDAP Reports Second Quarter 2013 Results
GlobeNewswire - Wed Aug 28, 6:30AM CDT
-- Received CE mark for innovative robotic HIFU device Focal One
CORRECTING AND REPLACING -- EDAP to Present at Rodman & Renshaw Annual Global Investment Conference, 15th Annual Healthcare Conference Sponsored by H.C. Wainwright & Co.
GlobeNewswire - Mon Aug 26, 8:53AM CDT
In a release issued under the same headline earlier today by EDAP TMS SA (Nasdaq:EDAP), please note that the presentation time should be 10:50 am ET - 11:15 am ET, rather than 10:25 am ET - 10:50 am ET as originally stated. The corrected release follows:
EDAP to Present at Rodman & Renshaw Annual Global Investment Conference, 15th Annual Healthcare Conference Sponsored by H.C. Wainwright & Co.
GlobeNewswire - Mon Aug 26, 7:30AM CDT
EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that Marc Oczachowski, Chief Executive Officer, and Eric Soyer, Chief Financial Officer, are scheduled to present at the Rodman & Renshaw Annual Global Investment Conference that will be held in New York City from September 8 to 10, 2013.
EDAP Schedules Webcast and Conference Call for Second Quarter 2013 Results
GlobeNewswire - Tue Aug 13, 7:30AM CDT
EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today details relating to its second quarter 2013 results announcement, which will take place on Wednesday, August 28, 2013, before the opening of the market.
EDAP Granted European Market Clearance for Focal.One(R)
GlobeNewswire - Tue Jun 18, 8:06AM CDT
EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that it received CE Mark (European regulatory approval) for Focal.One, its new and innovative robotic HIFU device fully dedicated to focal therapy of prostate cancer. Focal.One was showcased as world premiere at the European Urology Association Congress in Milan, Italy on March 15-19, 2013.
Market Maker Surveillance Report. PXLW, EDAP, SGOC, ORMP, GNMK, CERE, Losing Stocks With Lowest Price Friction For Monday, June 17th 2013
M2 - Tue Jun 18, 4:07AM CDT
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Monday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Monday there were 4039 companies with "abnormal" market making, 3102 companies with positive Friction Factors and 2091 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage loss per share Monday and low price friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. Pixelworks Inc (NASDAQ
XLW), Edap - Tms SA (NASDAQ:EDAP), SOLOMON GOLD CORP (NASDAQ:SGOC), Oramed Pharmaceuticals Inc (OTC:ORMP), Genmark Diagnostics Inc (NASDAQ:GNMK), Ceres Inc (NASDAQ:CERE). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on al
EDAP Fully Redeems $8.0 Million Long-Term Debt
GlobeNewswire - Fri Jun 14, 8:00AM CDT
EDAP TMS SA (Nasdaq:EDAP), a global leader in therapeutic ultrasound, announced today the full redemption of its $8.0 million outstanding long-term debt by using a portion of the net proceeds from the $12.0 million private placement executed on May 28, 2013.
Global Ablation Technologies Market Report 2012-2016: Boston Scientific, Medtronic, St Jude Medical and Varian Medical Dominate the Industry
M2 - Tue Jun 11, 9:31AM CDT
Research and Markets (http://www.researchandmarkets.com/research/gf85bm/global_ablation) has announced the addition of the "Global Ablation Technologies Market 2012-2016" report to their offering. Global Ablation Technologies market to grow at a CAGR of 10.52 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increased demand for minimally invasive surgical procedures. The Global Ablation Technologies market has also been witnessing the trend of miniaturizing medical devices. However, the varying regulations for medical devices could pose a challenge to the growth of this market. Global Ablation Technologies market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Global Ablation Technologies market in the Americas, the EMEA, and the APAC regions; it also covers the Global Ablation Technologies market by segmentation. The market landscape of the Global Thermal Ablation Technologies mar
Siemens Healthcare Market Share Analysis Report
M2 - Mon Jun 10, 9:01AM CDT
Research and Markets (http://www.researchandmarkets.com/research/q4kgsg/siemens) has announced the addition of the "Siemens Healthcare Market Share Analysis" company profile to their offering. This report provides in-depth information on Siemens Healthcare's market position in the different medical equipment markets it operates in. The report provides Siemens Healthcare market share information in eighteen key market categories - Hearing Aid Devices - Clinical Chemistry - Genetic Testing - Haematology - Immuno Chemistry - Infectious Immunology - Microbiology Culture - Angio Suites - C-Arms - Computed Tomography Systems - Mammography Equipment - MRI Systems - Nuclear Imaging Equipment - Ultrasound Systems - X-ray Systems - Lithotripters - Clinical IT Systems - Medical Imaging Information Systems. The report also provides data and information on the overall competitive landscape of the markets, the company operates in. The report is supplemented with global corporate-level profile with information on the c
EDAP's HIFU and Lithotripsy Devices Highlighted at 29th Annual EAU Congress
GlobeNewswire - Thu Apr 10, 7:30AM CDT
EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced its participation at the European Association of Urology (EAU) 2014 Annual Congress that will be held in Stockholm on April 11-15, 2014. EDAP's HIFU and lithotripsy device portfolio will be featured in multiple poster sessions.
EDAP Reports Fourth Quarter 2013 and Full Year Results
GlobeNewswire - Thu Apr 03, 6:30AM CDT
Highlights
EDAP Completes FDA Q&A Session for Its Ablatherm-HIFU Pre-Market Approval Application
GlobeNewswire - Thu Mar 20, 10:01AM CDT
EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that it has completed its response to questions from the FDA regarding the Company's Ablatherm-HIFU Pre-Market Approval ("PMA"
application, closing this step within the U.S. Food and Drug Administration ("FDA" review process. Global Ablation Technologies Market 2012-2016: Major Cancer Diseases that Use Ablation Technology Devices are Discussed in Detail
M2 - Mon Mar 10, 11:24AM CDT
Research and Markets (http://www.researchandmarkets.com/research/5z78kx/global_ablation) has announced the addition of the "Global Ablation Technologies Market 2012-2016" report to their offering. The analysts forecast the Global Ablation Technologies market to grow at a CAGR of 10.52 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increased demand for minimally invasive surgical procedures. The Global Ablation Technologies market has also been witnessing the trend of miniaturizing medical devices. However, the varying regulations for medical devices could pose a challenge to the growth of this market. Ablation technology devices are used for various clinical applications and Cancer therapy, and accounted for the largest segment of the Global Ablation Technologies market. The key vendors dominating this market space include Boston Scientific Corp., Medtronic Inc., St.Jude Medical Inc., and Varian Medical Systems Inc. The other vendors mentioned in the report are Accuray Inc., Alcon Laboratories Inc., AngioDynamics Inc., Arthrocare Corp., Atricure Inc., ATS Medical Inc., Biosense Webster Inc., BSD Medical Corporation, C.R. Bard Inc., Candela Corp., CardioGenesis Corp., CermaVEIN SAS, ConMed Corporation, Covidien plc, EDAP TMS S.A., Elekta AB, Endo Health Solutions Inc., Galil Medical Ltd., HealthTronics Inc., Hologic Inc., Idoman Ltd., Maquet Holding GmbH and Co. KG (Gentinge AB group), Microsulis Medical Ltd, Misonix Inc., nContact Surgical Inc., Olympus Corp., Relievant Medsystems, Rhythmia Medical Inc., Smith and Nephew plc, Solta Medical Inc., Syneron Medical Ltd., TheraGenics Corp., Urologix Inc., VNUS Medical Technologies Inc., and Zeltiq Aesthetics Inc. Commenting on the report, an analyst from the Healthcare team said: One of the upcoming trends in the Global Ablation Technology market is the rapid advancements in technology using ablation technology devices. Although the market for ablation technology devices is at a mature stage, the level of technology is still at a nascent stage; more devices with cutting-edge technology are expected to be introduced in the near future. Recently, laser ablation devices have been introduced to perform precise ablation of body tissue; these devices run on a laser energy transmission mechanism using fiber optics. This kind of device is used in transmyocardial revascularization and angioplasty. Another major advancement is the usage of catheter ablation for atrial fibrillation, which is commonly used to control tachy-arrhythmia. Thus, the rapid advancement in technology is an emerging trend that has a strong impact on the market. For more information visit http://www.researchandmarkets.com/research/5z...l_ablation About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
PowerShares Canada to adjust NAV on three ETFs
CNW Group - Thu Feb 20, 5:00PM CST
PowerShares Canada announced today that it will adjust the net asset value (NAV) of three TSX-listed PowerShares exchange-traded funds (the "ETFs"
effective Friday, February 21, 2014. EDAP Delivers Focal One(R) Device for Focal Treatment of Prostate Cancer to Hospital in Poland
GlobeNewswire - Tue Feb 11, 7:30AM CST
EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today the installation of its Focal One device at the ESKULAP Private Hospital in Bydgoszcz, Poland. Focal One is the first robotic HIFU device dedicated to the focal approach for prostate cancer therapy. It combines the three essential components to efficiently perform a focal treatment: state-of-the-art imaging to localized tumors with the use of magnetic resonance imaging (MRI) combined with real-time ultrasound, utmost precision of robotic HIFU treatment focused only on identified targeted cancer areas, and immediate feedback on treatment efficacy utilizing Contrast-Enhanced Ultrasound Imaging.
EDAP Schedules Webcast and Conference Call for Fourth Quarter and Full Year 2013 Results
GlobeNewswire - Mon Feb 10, 7:41AM CST
EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today details relating to its fourth quarter and full year 2013 results announcement, which will take place on Thursday, April 3, 2014, before the opening of the market.
EDAP Reports Third Quarter 2013 Results
GlobeNewswire - Thu Nov 21, 6:30AM CST
EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today financial results for the third quarter ended September 30, 2013.
EDAP Schedules Webcast and Conference Call for Third Quarter 2013 Results
GlobeNewswire - Thu Oct 31, 7:30AM CDT
EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today details relating to its third quarter 2013 results announcement, which will take place on Thursday, November 21, 2013, before the opening of the market.
EDAP's Ablatherm-HIFU to be Showcased at 31st World Congress of Endourology
GlobeNewswire - Tue Oct 22, 8:00AM CDT
EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that its high-intensity focused ultrasound (HIFU) for the treatment of localized prostate cancer, Ablatherm-HIFU, will be featured in multiple presentations addressing minimally invasive prostate cancer therapies and the successful evaluation of EDAP's device at the 31 World Congress of Endourology (WCE). Top level technical presentations will be made from key opinion leaders in urology, including Dr. Chaussy Christian, Department of Urology, University of Regensburg, Dr. Thuroff Stefan, Department of Urology, Klinikum Munchen Harlaching, and Dr. Sebastian Crouzet, Urologist at Edouard Herriot Hospital in Lyon, France. The WCE is scheduled to take place from October 22-26, 2013, in New Orleans, LA.
OTC Daily Alert Stock Watch - EDAP TMS S.A (NASDAQ: EDAP)
WorldStockWire - Tue Sep 17, 1:46AM CDT
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com
EDAP Reports Second Quarter 2013 Results
GlobeNewswire - Wed Aug 28, 6:30AM CDT
-- Received CE mark for innovative robotic HIFU device Focal One
CORRECTING AND REPLACING -- EDAP to Present at Rodman & Renshaw Annual Global Investment Conference, 15th Annual Healthcare Conference Sponsored by H.C. Wainwright & Co.
GlobeNewswire - Mon Aug 26, 8:53AM CDT
In a release issued under the same headline earlier today by EDAP TMS SA (Nasdaq:EDAP), please note that the presentation time should be 10:50 am ET - 11:15 am ET, rather than 10:25 am ET - 10:50 am ET as originally stated. The corrected release follows:
EDAP to Present at Rodman & Renshaw Annual Global Investment Conference, 15th Annual Healthcare Conference Sponsored by H.C. Wainwright & Co.
GlobeNewswire - Mon Aug 26, 7:30AM CDT
EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that Marc Oczachowski, Chief Executive Officer, and Eric Soyer, Chief Financial Officer, are scheduled to present at the Rodman & Renshaw Annual Global Investment Conference that will be held in New York City from September 8 to 10, 2013.
EDAP Schedules Webcast and Conference Call for Second Quarter 2013 Results
GlobeNewswire - Tue Aug 13, 7:30AM CDT
EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today details relating to its second quarter 2013 results announcement, which will take place on Wednesday, August 28, 2013, before the opening of the market.
EDAP Granted European Market Clearance for Focal.One(R)
GlobeNewswire - Tue Jun 18, 8:06AM CDT
EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that it received CE Mark (European regulatory approval) for Focal.One, its new and innovative robotic HIFU device fully dedicated to focal therapy of prostate cancer. Focal.One was showcased as world premiere at the European Urology Association Congress in Milan, Italy on March 15-19, 2013.
Market Maker Surveillance Report. PXLW, EDAP, SGOC, ORMP, GNMK, CERE, Losing Stocks With Lowest Price Friction For Monday, June 17th 2013
M2 - Tue Jun 18, 4:07AM CDT
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Monday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Monday there were 4039 companies with "abnormal" market making, 3102 companies with positive Friction Factors and 2091 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage loss per share Monday and low price friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. Pixelworks Inc (NASDAQ
XLW), Edap - Tms SA (NASDAQ:EDAP), SOLOMON GOLD CORP (NASDAQ:SGOC), Oramed Pharmaceuticals Inc (OTC:ORMP), Genmark Diagnostics Inc (NASDAQ:GNMK), Ceres Inc (NASDAQ:CERE). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on al EDAP Fully Redeems $8.0 Million Long-Term Debt
GlobeNewswire - Fri Jun 14, 8:00AM CDT
EDAP TMS SA (Nasdaq:EDAP), a global leader in therapeutic ultrasound, announced today the full redemption of its $8.0 million outstanding long-term debt by using a portion of the net proceeds from the $12.0 million private placement executed on May 28, 2013.
Global Ablation Technologies Market Report 2012-2016: Boston Scientific, Medtronic, St Jude Medical and Varian Medical Dominate the Industry
M2 - Tue Jun 11, 9:31AM CDT
Research and Markets (http://www.researchandmarkets.com/research/gf85bm/global_ablation) has announced the addition of the "Global Ablation Technologies Market 2012-2016" report to their offering. Global Ablation Technologies market to grow at a CAGR of 10.52 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increased demand for minimally invasive surgical procedures. The Global Ablation Technologies market has also been witnessing the trend of miniaturizing medical devices. However, the varying regulations for medical devices could pose a challenge to the growth of this market. Global Ablation Technologies market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Global Ablation Technologies market in the Americas, the EMEA, and the APAC regions; it also covers the Global Ablation Technologies market by segmentation. The market landscape of the Global Thermal Ablation Technologies mar
Siemens Healthcare Market Share Analysis Report
M2 - Mon Jun 10, 9:01AM CDT
Research and Markets (http://www.researchandmarkets.com/research/q4kgsg/siemens) has announced the addition of the "Siemens Healthcare Market Share Analysis" company profile to their offering. This report provides in-depth information on Siemens Healthcare's market position in the different medical equipment markets it operates in. The report provides Siemens Healthcare market share information in eighteen key market categories - Hearing Aid Devices - Clinical Chemistry - Genetic Testing - Haematology - Immuno Chemistry - Infectious Immunology - Microbiology Culture - Angio Suites - C-Arms - Computed Tomography Systems - Mammography Equipment - MRI Systems - Nuclear Imaging Equipment - Ultrasound Systems - X-ray Systems - Lithotripters - Clinical IT Systems - Medical Imaging Information Systems. The report also provides data and information on the overall competitive landscape of the markets, the company operates in. The report is supplemented with global corporate-level profile with information on the c
